Premium
Differential expression of p63 isoforms in normal skin and hyperproliferative conditions
Author(s) -
Kim SoYoung,
Cho HyunJoo,
Kim DongSeok,
Choi HaeRyung,
Kwon SunBang,
Na JungIm,
Jeon HyeChan,
Huh ChangHoon,
Youn SangWoong,
Cho KwangHyun,
Park KyoungChan
Publication year - 2009
Publication title -
journal of cutaneous pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 75
eISSN - 1600-0560
pISSN - 0303-6987
DOI - 10.1111/j.1600-0560.2008.01167.x
Subject(s) - epidermis (zoology) , psoriasis , basal (medicine) , gene isoform , blot , pathology , western blot , biology , medicine , immunology , anatomy , endocrinology , gene , genetics , insulin
Background: The p63 is regarded as a potential stem cell marker. Methods: Expression of p63 isoforms was examined in normal skin and hyperproliferative conditions including psoriasis and artificial skin equivalents (SEs). Rapidly adhering (RA) and slowly adhering (SA) cells were isolated, and Western blotting was performed. Results: Expression of p63 (4A4) and p63 (H‐137) is similar in all conditions, although there is some variation in psoriasis. However, expression of p63α (C‐12) is markedly different. In normal skin, p63α (C‐12)‐positive cells were scattered in whole epidermis. But in psoriasis, p63α (C‐12)‐positive cells were observed at the tips of rete ridges. In SEs, p63α (C‐12)‐positive cells were not well observed. Western blot results showed that the RA cells express p63 (4A4) and p63 (H‐137) strongly compared with SA or nonadhering (NA) cells. In contrast, SA or NA cells strongly express p63α (C‐12). Conclusions: Results suggest that both p63 (4A4) and p63 (H‐137) can detect epidermal stem cells. But, p63 (H‐137) seemed to be a better marker because p63 (H‐137)‐positive cells were more localized at basal layer. In addition, it can be said that p63α (C‐12) can detect TAp63, which is important in differentiation of epidermis. Furthermore, it is concluded that molecular control of TAp63 is especially disorganized in hyperproliferative condition including psoriasis and SEs.